Abstract
Parathyroid hormone (PTH) is a major mediator of calcium and phosphate metabolism through its interactions with receptors in kidney and bone. PTH binds with high affinity to PTH1 and PTH2, members of the superfamily of G protein-coupled receptors. In order to clone the canine PTH1 receptor, a canine kidney cDNA library was screened using the human PTH1 receptor cDNA and two clones were further characterized. The longest clone was 2177 bp and contained a single open reading frame of 1785 bp, potentially encoding a protein of 595 amino acids with a predicted molecular weight of 66.4 kD. This open reading frame exhibits >91% identity to the human PTH1 receptor cDNA and >95% identity when the putative canine and human protein sequences are compared. Competition binding following transfection of the canine PTH1 receptor into CHO cells demonstrated specific displacement of 125I-human PTH 1-34 by canine PTH 1-34, human PTH 1-34, and canine/human parathyroid hormone related peptide (PTHrP) 1-34. Treatment of canine PTH1 receptor transfected cells, but not mock transfected cells, with these ligands also resulted in increased levels of intracellular cAMP. In contrast, the non-related aldosterone secretion inhibiting factor 1-35 neither bound nor activated the canine PTH1 receptor. Northern blot analysis revealed high levels of PTH1 receptor mRNA in the kidney, with much lower, but detectable, levels in aorta, heart, lung, prostate, testis, and skeletal muscle. Together, these data indicate that we have cloned the canine PTH1 receptor and that it is very similar, both in sequence and in functional characteristics, to the other known PTH1 receptors.
Similar content being viewed by others
References
Karaplis AC & Goltzman D (2000) Rev. Endocrine Metabolic Disorders 1: 331–341
Mannstadt M, Juppner H & Gardella TJ (1999) Am. J. Physiol. 277: F665–F675
Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY, Hudson PJ, Martin TJ & Wood WI (1987) Science 237: 893–896
Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall REH, Kemp BE, Suva LJ, Rodda CP, Ebeling PR, Hudson PJ, Zajac JD & Martin TJ (1987) Proc. Natl. Acad. Sci. USA 84: 5048–5052
Mangin M, Webb AC, Dreyer BE, Posillico JT, Ikeda K, Weir EC, Stewart AF, Bander NH, Milstone L, Barton DE, Francke U & Broadus AE (1988) Proc. Natl. Acad. Sci. USA 85: 597–601
Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M & Nissenson RA (1987) J. Clin. Invest. 80: 1803–1807
Jüppner H, Abou-Samra A-B, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF, Hock J, Potts JT, Kronenberg HM & Segre GV (1991) Science 254: 1024–1026
Schipani E, Karga H, Karaplis AC, Potts JT, Kronenberg HM, Segre GV, Abou-Samra A-B & Jüppner H (1993) Endocrinol 132: 2157–2165
Gether U (2000) Endocrine Rev. 21: 90–113
Usdin TB, Gruber C & Bonner TI (1995) J. Biol. Chem. 270: 15455–15458
Usdin TB, Bonnor TI, Harta G & Mezey E (1996) Endocrinol 137: 4285–4297
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH, Mellstrom D, Oefjord ES, Marcinowska-Suchowierska E, Salmi J, Mulder H, Halse J & Sawicki AZ (2001) N. Engl. J. Med. 344: 1434–1441
Cosman F, Nieves J, Woelfert L, Formica C, Gordon S, Shen V & Lindsay R (2001) J. Bone Miner. Res. 16: 925–931
Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D & Cosman F (1997) Lancet 350: 550–555
Dempster DW, Cosman F, Parisien M, Shen V & Lindsay R (1993) Endocrine Rev. 14: 690–709
Sambrook J, Fritsch EF & Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Press, Cold Spring Harbor, NY
Castleberry TA, Lu B, Smock SL & Owen TA (2001) Prostaglandins and Other Lipid Mediators 65: 167–187
Rosol TJ, Steinmeyer CL, McCauley LK, Gröne A, DeWille JW & Capen CC (1995) Gene 160: 241–243
Kozak M (1989) J. Cell Biol. 108: 229–241
Kong X-F, Schipani E, Lanske B, Joun H, Karperien M, De-fize LHK, Jüppner H, Potts JT, Segre GV, Kronenberg HM & Abou-Samra A-B (1994) Biochem. Biophys. Res. Comm. 200: 1290–1299
Kyte J & Doolittle RF (1982) J. Mol. Biol. 157: 105–132
Schneider H, Feyen JHM, Seuwen K & Movva NR (1993) Eur. J. Pharm. 246: 149–155
Jüppner H, Brown EM & Kronenberg HM (1999) In: Favus MJ, (Ed) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (pp. 80–87) Lippincott, Williams, and Wilkins, Philadelphia, PA
Jobert A-S, Zhang P, Couvineau A, Bonaventure J, Roume J, Le Merrer M & Silve C (1998) J. Clin. Invest. 102: 34–40
Schipani E, Kruse K & Jüppner H (1995) Science 268: 98–100
Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LHK, Ho C, Mulligan RC, Abou-Samra A-B, Jüppner H, Segre GV & Kronenber HM (1996) Science 273: 663–666
Lanske B, Amling M, Neff L, Guiducci J, Baron R & Kronenberg HM (1999) J. Clin. Invest. 104: 399–407
Urena P, Kong X-F, Abou-Samra A-B, Juppner H, Kronenberg HM, Potts JT & Segre GV (1993) Endocrinol 133: 617–623
Abou-Samra A-B, Jüppner H, Force T, Freeman MW, Kong X-F, Schipani E, Urena P, Richards J, Bonventre JV, Potts JT, Kronenberg HM & Segre GV (1992) Proc. Natl. Acad. Sci. USA 89: 2732–2736
Karperien M, van Dijk TB, Heoijmakers T, Cremers F, Abou-Samra A-B, Boonstra J, de Laat SW & Defize LH (1994) Mech. Develop. 47: 29–42
Karpf DB, Arnaud CD, King K, Bambino T, Winer J, Nyiredy K & Nissenson RA (1987) Biochemistry 26: 7825–7833
Orloff JJ, Goumas D, Wu TL & Stewart AF (1991) J. Bone Min. Res. 6: 279–286
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smock, S., Vogt, G., Castleberry, T. et al. Molecular cloning and functional characterization of the canine parathyroid hormone/parathyroid hormone related peptide receptor (PTH1). Mol Biol Rep 28, 235–243 (2001). https://doi.org/10.1023/A:1015716726452
Issue Date:
DOI: https://doi.org/10.1023/A:1015716726452